Related references
Note: Only part of the references are listed.Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung
Hope E. Karnes et al.
CANCER CYTOPATHOLOGY (2014)
The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets
Steven L. Wood et al.
CANCER TREATMENT REVIEWS (2014)
Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma
Hye Ryun Kim et al.
LUNG CANCER (2014)
A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material
N. G. Bediaga et al.
BRITISH JOURNAL OF CANCER (2013)
Clinical Next-Generation Sequencing Successfully Applied to Fine-Needle Aspirations of Pulmonary and Pancreatic Neoplasms
Geneva Young et al.
CANCER CYTOPATHOLOGY (2013)
Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas
Renu Khode et al.
CANCER CYTOPATHOLOGY (2013)
Treatment of Stage IV Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Mark A. Socinski et al.
CHEST (2013)
Effective Assessment of egfr Mutation Status in Bronchoalveolar Lavage and Pleural Fluids by Next-Generation Sequencing
Fiamma Buttitta et al.
CLINICAL CANCER RESEARCH (2013)
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
Neal I. Lindeman et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Molecular Typing of Lung Adenocarcinoma on Cytological Samples Using a Multigene Next Generation Sequencing Panel
Aldo Scarpa et al.
PLOS ONE (2013)
Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy)
Dario de Biase et al.
PLOS ONE (2013)
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins
Monika A. Davare et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Applications and limitations of oncogene mutation testing in clinical cytopathology
Claudio Bellevicine et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2013)
Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer
Yan Liu et al.
CANCER DISCOVERY (2013)
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing
Pengyuan Liu et al.
CARCINOGENESIS (2012)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
KIF5B-RET fusions in lung adenocarcinoma
Takashi Kohno et al.
NATURE MEDICINE (2012)
RET, ROS1 and ALK fusions in lung cancer
Kengo Takeuchi et al.
NATURE MEDICINE (2012)
Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status
She-Juan An et al.
PLOS ONE (2012)
EGFR and KRAS Mutations in Lung Carcinoma Molecular Testing by Using Cytology Specimens
Shahreen Billah et al.
CANCER CYTOPATHOLOGY (2011)
EGFR Mutation Status in Primary Lung Adenocarcinomas and Corresponding Metastatic Lesions: Discordance in Pleural Metastases
Hye-Suk Han et al.
CLINICAL LUNG CANCER (2011)
Role of Cytology in the Management of Non-Small-Cell Lung Cancer.
Andrew H. Fischer et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases
Sara E. Monaco et al.
HUMAN PATHOLOGY (2010)
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
C. -H. Gow et al.
ANNALS OF ONCOLOGY (2009)
EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases
Katharina Schmid et al.
CLINICAL CANCER RESEARCH (2009)
Discordance of Molecular Biomarkers Associated with Epidermal Growth Factor Receptor Pathway between Primary Tumors and Lymph Node Metastasis in Non-small Cell Lung Cancer
Sarah Park et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer
Lorenzo Daniele et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC
A. Kalikaki et al.
BRITISH JOURNAL OF CANCER (2008)
Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites
Cecilia Bozzetti et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Share Paper
